Coherus Oncology (CHRS) EBT Margin Growth (1y) (2014 - 2026)
Coherus Oncology (CHRS) EBT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 813.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Coherus Oncology | 194.37 Mn | 27.32 Mn | 8.50 Mn | 32,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32,370.00 |
| Dec 31, 2025 | 23,249.00 |
| Sep 30, 2025 | 40,177.00 |
| Jun 30, 2025 | 9,523.00 |
| Mar 31, 2025 | 232,409.00 |
| Dec 31, 2024 | -50,903.00 |
| Sep 30, 2024 | -73,283.00 |
| Jun 30, 2024 | -45,973.00 |
| Mar 31, 2024 | -271,436.00 |
| Dec 31, 2023 | 4,278.00 |
| Sep 30, 2023 | 13,709.00 |
| Jun 30, 2023 | 1,036.00 |
| Mar 31, 2023 | -7,364.00 |
| Dec 31, 2022 | -6,753.00 |
| Sep 30, 2022 | -14,406.00 |
| Jun 30, 2022 | -4,926.00 |
| Mar 31, 2022 | 4,845.00 |
| Dec 31, 2021 | -7,202.00 |
| Sep 30, 2021 | -7,146.00 |
| Jun 30, 2021 | -7,858.00 |